ATE432270T1 - Verfahren zu herstellung von lovastatin. - Google Patents
Verfahren zu herstellung von lovastatin.Info
- Publication number
- ATE432270T1 ATE432270T1 AT03782759T AT03782759T ATE432270T1 AT E432270 T1 ATE432270 T1 AT E432270T1 AT 03782759 T AT03782759 T AT 03782759T AT 03782759 T AT03782759 T AT 03782759T AT E432270 T1 ATE432270 T1 AT E432270T1
- Authority
- AT
- Austria
- Prior art keywords
- lovastatin
- impure
- producing lovastatin
- producing
- lactonisation
- Prior art date
Links
- QLJODMDSTUBWDW-UHFFFAOYSA-N lovastatin hydroxy acid Natural products C1=CC(C)C(CCC(O)CC(O)CC(O)=O)C2C(OC(=O)C(C)CC)CC(C)C=C21 QLJODMDSTUBWDW-UHFFFAOYSA-N 0.000 title abstract 6
- PCZOHLXUXFIOCF-UHFFFAOYSA-N Monacolin X Natural products C12C(OC(=O)C(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 PCZOHLXUXFIOCF-UHFFFAOYSA-N 0.000 title abstract 5
- PCZOHLXUXFIOCF-BXMDZJJMSA-N lovastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 PCZOHLXUXFIOCF-BXMDZJJMSA-N 0.000 title abstract 5
- 229960004844 lovastatin Drugs 0.000 title abstract 5
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 abstract 2
- QLJODMDSTUBWDW-BXMDZJJMSA-N mevinolinic acid Chemical compound C1=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@H]2[C@@H](OC(=O)[C@@H](C)CC)C[C@@H](C)C=C21 QLJODMDSTUBWDW-BXMDZJJMSA-N 0.000 abstract 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 abstract 1
- 238000002955 isolation Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000000746 purification Methods 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/30—Oxygen atoms, e.g. delta-lactones
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IN2003/000333 WO2005035515A1 (en) | 2003-10-14 | 2003-10-14 | A method for the manufacture of lovastatin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE432270T1 true ATE432270T1 (de) | 2009-06-15 |
Family
ID=34430672
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03782759T ATE432270T1 (de) | 2003-10-14 | 2003-10-14 | Verfahren zu herstellung von lovastatin. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7566792B2 (de) |
| EP (1) | EP1673361B1 (de) |
| AT (1) | ATE432270T1 (de) |
| AU (1) | AU2003290396A1 (de) |
| CA (1) | CA2540068C (de) |
| DE (1) | DE60327813D1 (de) |
| ES (1) | ES2325498T3 (de) |
| PT (1) | PT1673361E (de) |
| WO (1) | WO2005035515A1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102993145B (zh) * | 2011-09-19 | 2015-06-03 | 北大方正集团有限公司 | 一种提取纯化洛伐他汀的方法 |
| EP2597092A1 (de) * | 2011-11-24 | 2013-05-29 | Sterling Biotech Limited | Verfahren zum Reinigen von Lovastatin |
| CN111718317A (zh) * | 2019-03-21 | 2020-09-29 | 福安药业集团烟台只楚药业有限公司 | 一种洛伐他汀的提炼方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA44922C2 (uk) * | 1995-12-06 | 2002-03-15 | Балканфарма-Разград Ад | Спосіб одержання ловастатину |
| SI20527A (sl) | 1999-06-29 | 2001-10-31 | Kaneka Corporation | Postopek za selektivno laktonizacijo |
| EP1228057A2 (de) * | 1999-10-27 | 2002-08-07 | Merck & Co., Inc. | Laktonbildungsverfahren |
| IN192861B (de) * | 2000-06-30 | 2004-05-22 | Ranbaxy Lab Ltd |
-
2003
- 2003-10-14 AU AU2003290396A patent/AU2003290396A1/en not_active Abandoned
- 2003-10-14 PT PT03782759T patent/PT1673361E/pt unknown
- 2003-10-14 EP EP03782759A patent/EP1673361B1/de not_active Expired - Lifetime
- 2003-10-14 US US10/571,192 patent/US7566792B2/en not_active Expired - Fee Related
- 2003-10-14 WO PCT/IN2003/000333 patent/WO2005035515A1/en active Application Filing
- 2003-10-14 CA CA2540068A patent/CA2540068C/en not_active Expired - Fee Related
- 2003-10-14 DE DE60327813T patent/DE60327813D1/de not_active Expired - Lifetime
- 2003-10-14 ES ES03782759T patent/ES2325498T3/es not_active Expired - Lifetime
- 2003-10-14 AT AT03782759T patent/ATE432270T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ES2325498T3 (es) | 2009-09-07 |
| EP1673361B1 (de) | 2009-05-27 |
| CA2540068C (en) | 2012-05-29 |
| WO2005035515A1 (en) | 2005-04-21 |
| EP1673361A1 (de) | 2006-06-28 |
| PT1673361E (pt) | 2009-07-13 |
| DE60327813D1 (de) | 2009-07-09 |
| CA2540068A1 (en) | 2003-10-14 |
| AU2003290396A1 (en) | 2005-04-27 |
| US7566792B2 (en) | 2009-07-28 |
| US20070238885A1 (en) | 2007-10-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60306667D1 (de) | Cefdinir salze als zwischenprodukte | |
| ATE264268T1 (de) | Verfahren zur herstellung von zsm-5 und zsm-11 | |
| ATE455087T1 (de) | Verfahren zur herstellung von 2,5- dimethylphenylessigsäure | |
| ATE323777T1 (de) | Verfahren zur herstellung von lysophosphatidyl- ethanolamin | |
| ATE445601T1 (de) | Verfahren zur herstellung von carvedilol und seinen enantiomeren | |
| ATE457972T1 (de) | Verfahren zur herstellung von 7-amino-syn-3,5- dihydroxyheptansäurederivaten und zwischenverbindungen diesesverfahrens und deren herestellung | |
| ATE359272T1 (de) | Verfahren zur herstellung von 3-hydroxy-n-1,6- | |
| ATE407127T1 (de) | Verfahren zur herstellung von beraprost und dessen salzen | |
| ATE432270T1 (de) | Verfahren zu herstellung von lovastatin. | |
| DE69908909T2 (de) | Verfahren zur herstellung von simvastatin und ihren derivaten | |
| ATE281434T1 (de) | Verfahren zur herstellung von benzoperhydroisoindolen | |
| ATE415404T1 (de) | Lösungsmittelfreies verfahren zur herstellung von diketopyrrolopyrrol-derivaten | |
| ATE372332T1 (de) | Verfahren zur herstellung von zwischenverbindungen in der herstellung von discodermolid und discodermolid-analoga | |
| ATE496038T1 (de) | Verfahren zur herstellung von quetiapin | |
| DE60107292D1 (de) | Verfahren zur herstellung von (+)-trans-4-p-fluorophenyl-3-hydroxymethyl-1-methylpiperidin | |
| ATE399757T1 (de) | Neues verfahren zur herstellung von nitrooxyderivaten von paracetamol | |
| ATE417826T1 (de) | Verfahren zur herstellung von zwischenprodukten | |
| ATE363460T1 (de) | Verfahren zur herstellung von fluorhalogenalkanen | |
| ATE457304T1 (de) | Verfahren zur herstellung von 1,2-dichlorethan freien kristallen von zonisamid und hochreinezonisamidkristalle | |
| ATE300534T1 (de) | Verfahren und zwischenverbindungen zur herstellung von imidazopyridinen | |
| ATE375355T1 (de) | Verfahren zur herstellung von cefpodoxim-proxetil | |
| ATE451347T1 (de) | N-methyl-homocysteine und ihre verwendung sowie verfahren zu ihrer herstellung | |
| ATE330612T1 (de) | Verfahren zur herstellung von benazeprilhydrochloride | |
| ATE309226T1 (de) | Verfahren zur herstellung von fluconazole und kristallmodifikationen davon | |
| ATE297478T1 (de) | Verfahren zur herstellung von orthocarbonsäuretrialkylestern |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |